Is It Time to Inform This Patient that Further Antineoplastic Drug Therapy Will Not Be of Clinical Value?
نویسنده
چکیده
A woman with heavy pre-treated ovarian cancer sought consultation regarding additional treatments. The case raises the vexing question of whether there may be a time in the course of the disease process where it is most appropriate to state further anti-neoplastic therapy will not be of clinical utility.
منابع مشابه
Targeted cancer therapy: review article
Cancer is one of the most dangerous health problems of today modern societies which has an increasing rate especially in developing countries. There are many diverse ongoing treatment attempts trying to defeat cancer. Despite that, scientists have been unable to find a permanent cure for this disease. In many cases although there is a successful first response in patients, cancer cells are fina...
متن کاملInvolvement of Patients in Health Technology Assessment: Further Perspectives for Informing Decision-Makers
Health technology assessment (HTA) is an evaluative process used to inform technology-related policymaking in healthcare. Interest in involving patients in the HTA process is increasing. Patients can provide additional perspectives to those of other groups that are concerned with health technology. Information on patients’ perspectives is preferably obtained through reviews of published studies...
متن کاملA Review on Some Aspects of Patient’ Rights in Clinical Education
Clinical education will be possible with involving patients. Many patients who seek medical and diagnostic care can be involved in clinical training. Therefore, teachers and students need to know the legal aspects of patient involvement and adhere to these aspects in order to attract patients’ participation and satisfaction. This study reviewed the importance and necessity of legal aspects, i...
متن کاملClinical Pharmacy in Iran: Where Do We Stand?
Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...
متن کاملClinical Pharmacy in Iran: Where Do We Stand?
Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...
متن کامل